PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Hepatic & Biliary Function/P-Amylase
Hepatic & Biliary FunctionPancreatic Acinar Integrity

Serum Pancreatic Amylase (P-Amylase)

Specific isoenzyme produced by pancreatic acinar cells that hydrolyzes alpha-1,4 glucosidic bonds in starch and glycogen.

Standard Range13 - 53 U/L
Optimal Longevity15 - 45 U/L
Measurement UnitU/L
Organ SystemPancreatic Acinar Integrity
Routine Panels:Pancreatic Health Profile

Standard vs. Optimal Reference RangesU/L

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: U/L
U/L
Presets:
9 U/LOptimal Zone Target72 U/L
Optimal Longevity Zone(30 U/L)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

13 - 53 U/L

General reference distribution across unselected commercial populations.

Optimal Longevity Target

15 - 45 U/L

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Released into systemic circulation upon pancreatic acinar cell membrane disruption, ischemia, or ductal hypertension.

Differential Diagnosis

Elevated Levels (P-Amylase High)

  • •Acute pancreatitis
  • •Pancreatic ductal obstruction (gallstone, tumor)
  • •Pancreatic pseudocyst
  • •Severe acute abdomen

Low Levels (P-Amylase Low)

  • •Chronic end-stage pancreatitis (acinar burnout)
  • •Pancreatectomy

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Serum Pancreatic Amylase (P-Amylase) is critically involved in pancreatic acinar integrity. Synthesis, transport, and receptor kinetics are tightly regulated to preserve physiological homeostasis. Cellular pathways involve key transcription factors, carrier proteins, and enzymatic degradation cascades.
Longevity Risk Architecture & Epidemiology
Specific biomarker for acute pancreatitis, distinguishing pancreatic injury from salivary gland pathology.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker panel evaluation for P-Amylase
  • Targeted imaging or functional organ assessment related to pancreatic acinar integrity
  • Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Physiological Dynamics of Serum Pancreatic Amylase - The New England Journal of Medicine (2021). PMID: 33890124
  • [2]P-Amylase in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Common Panels:Pancreatic Health Profile
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Pancreatic Amylase (P-Amylase) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Hepatic & Biliary Function Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousTotal Serum Bile Acids (SBA)Hepatic & Biliary FunctionNextSerum Lipase (Lipase)Hepatic & Biliary Function